The global medical flexible packaging market size was valued at USD 18.8 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.9% from 2023 to 2030. The growing pharmaceutical market in emerging economies and the growth of drug delivery systems are driving the market. Extensive use of flexible packaging solutions in the medical and pharmaceutical sectors on account of product variety, low weight, easy disposal, and requirement of less raw material is driving the market growth. The high-barrier film segment is estimated to be the fastest-growing product segment from 2023 to 2030. The demand for BOPET and polyvinylidene chloride barrier films is also expected to remain high over the forecast period due to the presence of many manufacturers. The major materials that are used for the manufacturing of flexible packaging products are plastics, paper, and aluminum, of which, the plastics material segment accounts for the largest share of the global market.
Higher tensile strength than their metal counterparts and a wide variety of options offered by plastic materials are expected to drive segment growth in the years to come. Over the past decade, the use of medical disposable products has increased significantly, driving the demand for medical flexible packaging. Numerous medical products used in healthcare facilities, such as trays, pre-filled syringes, needles, thermometers, and scalpels, are available as disposables.
Disposable products offer several advantages, such as the convenience of usage, sterility, and safety. Single-use disposables are also cost-effective and efficient as they eliminate the need to re-sterilize the product before use. The reduction of risk of cross-contamination is another key factor driving the demand for disposable products, which, in turn, is boosting the market growth.
The plastics segment led the market and accounted for more than 74.0% share of the global revenue in 2022. Plastics offer a wide variety of options and higher tensile strength than their metal counterparts, which is expected to drive segment growth over the forecast period. The innovation in extrusion technology and the presence of a large number of manufacturing facilities have improved the demand for plastics and paved the way for new product development in medical packaging. The most widely used plastic types include polyethylene, polyethylene terephthalate, polypropylene, and polyvinyl chloride.
Plastic is often used to retain the structure of packaging and makes it waterproof by adding a thin layer of plastic film in other types of packaging. The fluctuations in the price of oil affect the costs of plastics, which eventually affects the prices of plastic medical flexible packaging. However, the paper material segment is estimated to register the fastest CAGR from 2023 to 2030.
Innovations in the paper industry and the development of eco-friendly paper are expected to drive the segment over the forecast period. Moreover, the properties offered by paper materials, such as product safety, cleanliness, reliability, and ease of use, are estimated to boost their demand further. This type of packaging is gaining importance as it forms an important part of the branding strategy. The temperature resistance exhibited by these materials is also expected to drive the demand for paper-based products over the forecast period.
The pouches & bags segment led the market and accounted for more than 35.0% share of the global revenue in 2022. Pouches & bags are used for packaging a wide range of medical products. Amcor is one of the leading manufacturers and suppliers of pouches & bags in the healthcare industry. The development of special pouches & bags with high-barrier packaging is expected to drive the segment over the forecast period.
Lids & labels are majorly used to prevent the devices or pharmaceuticals from contamination, tampering, and spoilage. These products serve as the primary or secondary form of functional packaging. Labeling has become an important part of packaging due to the regulations concerning the labeling of medical devices. The demand for lids and labels is expected to grow moderately over the forecast period.
The high-barrier films segment is estimated to register the fastest CAGR from 2023 to 2030. These films prevent the permeation of light, gas, flavor, aroma, oxygen, oil, water vapor, and water and are mostly manufactured using ethylene vinyl alcohol, polyvinylidene chloride, polyacrylonitrile, and BOPET. The development of metalized films, manufactured using aluminum and silicon, is expected to propel the segment growth over the coming years.
The pharmaceutical manufacturing segment accounted for the largest revenue share of more than 29.0% in 2022. The preference of manufacturers to have an in-house packing facility is driving the consumption of packaging materials in this end-use segment. However, the demand is expected to decrease as manufacturers are outsourcing their packaging activities to gain significant cost advantages.
Medical device manufacturing is the second-largest end-use segment as the product demand in this segment has spiked especially after the pandemic. A rise in healthcare expenditure all over the world and increasing innovations are also boosting segment growth. Moreover, rising product usage by medical device manufacturing companies to improve the presentability of their product packaging will support segment growth.
The contract packaging segment is projected to be the fastest-growing end-use segment from 2023 to 2030. End-use manufacturers are taking advantage of significant cost-savings offered by packaging in developing countries. Such practices have made way for the growth of the contract packaging industry. Emerging economies are perceived as favorable destinations for the growth of contract packaging services. The product demand in the other end-use segment, which includes hospitals, retail & institutional pharmacy stores, is growing at a slow rate due to the maturity of the segment.
Asia Pacific was the largest regional market in 2022, accounting for a revenue share of more than 57.0%. It will expand further at the fastest CAGR from 2023 to 2030 due to the growing product demand from emerging economies, such as India and China. The rising per capita income coupled with the growing healthcare industry is also expected to have a positive impact on market development. Contract manufacturing will be one of the key end-use sectors in the region over the forecast period and is expected to present lucrative growth opportunities for medical flexible packaging manufacturers in the coming years.
North America accounted for a revenue share of over 22.0% in 2022. The product demand in the North America region is driven by an improving economic outlook and growing innovation on barrier materials. Moreover, the strong presence of major companies, such as Amcor and Bemis, is expected to further augment regional growth over the forecast period. In addition, with the increasing usage of drug delivery systems, such as IV bags and nutrition bags, product demand is increasing.
The declining growth of the pharmaceutical industry in France, Germany, and Italy on account of shifting manufacturing base to the regions with low manufacturing costs is expected to adversely affect the regional market. However, increasing R&D expenditure in the pharmaceutical industry in Europe is expected to indirectly fuel product demand over the forecast period.
Major companies exhibit strong control over the entire value chain. Companies in the market have been exploring data services and other allied businesses to attract more customers. The diversification strategy aimed at providing data services along with the current portfolio of products are expected to increase the market competition.
The key strategies adopted by major industry players include mergers & acquisitions, new product development, and regional expansion. Furthermore, manufacturers are looking at emerging countries as their market share is expected to grow over the forecast period. The growing demand for pharmaceuticals and medical devices in these regions will increase the product demand. Some prominent players in the global medical flexible packaging market include:
Bemis Company, Inc.
WestRock, Aptar, Inc.
Dätwyler Holding, Inc.
Becton, Dickinson & Company
Berry Global
Catalent Pharma Solutions
Coveris S.A.
Winpak Ltd.
Sealed Air
Amcor
Mondi
Huhtamäki Oyj
CCL Industries, Inc.
Gerresheimer
Report Attribute |
Details |
Market size value in 2023 |
USD 20.1 billion |
Revenue forecast in 2030 |
USD 32.00 billion |
Growth Rate |
CAGR of 6.9% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million, CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
Segments covered |
Product, material, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
Canada; U.S.; Mexico; Germany; France; U.K.; China; Japan; India; Brazil; South Africa |
Key companies profiled |
Bemis Company, Inc.; WestRock, Aptar, Inc.; Dätwyler Holding, Inc.; Becton, Dickinson & Company; Berry Global; Catalent Pharma Solutions; Coveris S.A.; Winpak Ltd.; Sealed Air; Amcor; Mondi; Huhtamäki Oyj; CCL Industries, Inc.; Gerresheimer |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2023 to 2030. For the purpose of this study, Grand View Research has segmented the global medical flexible packaging market report based on material, product, end-use, and region:
Material Outlook (Revenue, USD Million, 2018 - 2030)
Plastics
Polyvinyl Chloride
Polypropylene
Polyethylene Terephthalate
Polyethylene
Others
Paper
Aluminum
Bioplastics
Product Outlook (Revenue, USD Million, 2018 - 2030)
Seals
High Barrier Films
Biaxially Oriented Polyethylene Terephthalate (BOPET)
Ethylene Vinyl Alcohol (EVA)
Polyacrylonitrile
Silicon Oxide
Aluminum Oxide
Polyvinylidene Chloride
Others
Wraps
Pouches & Bags
Lids & Labels
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceutical Manufacturing
Medical Device Manufacturing
Implant Manufacturing
Contract Packaging
Others (Clinical Trials, Drug Testing, Pathology, and Medical clothing)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Asia Pacific
China
Japan
India
Central & South America (CSA)
Brazil
Middle East & Africa (MEA)
South Africa
b. The global medical flexible packaging market size was estimated at USD 18.8 billion in 2022 and is expected to reach USD 20.1 billion in 2023.
b. The global medical flexible packaging market is expected to grow at a compound annual growth rate of 6.9% from 2023 to 2030 to reach USD 32.0 billion by 2030.
b. The pouches & bags segment led the global medical flexible packaging market and accounted for more than 35.0% share of the global revenue in 2022.
b. The pharmaceutical manufacturing segment global medical flexible packaging market and accounted for the largest revenue share of more than 29.0% in 2022.
b. Asia Pacific was the largest regional market in 2022 accounting for a revenue share of more than 57.0%.
b. Plastics accounted for the largest segment in the global medical flexible packaging market with a share of over 74.0% in 2022.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.